Literature DB >> 16652421

Role of endothelial damage in the pathogenesis of interstitial pneumonitis in patients with polymyositis and dermatomyositis.

Masanori Funauchi1, Hideki Shimadsu, Chise Tamaki, Toshiaki Yamagata, Yuji Nozaki, Masafumi Sugiyama, Shinya Ikoma, Koji Kinoshita.   

Abstract

OBJECTIVE: Polymyositis and dermatomyositis (PM/DM) are often complicated by interstitial pneumonitis (IP), which is an important cause of death. It has been reported that blood concentration of transforming growth factor-beta (TGF-beta), which is produced by a wide range of cells including endothelial cells and enhances the fibrotic changes in various tissues, is increased in PM/DM with IP. Endothelial damage is likely to exist in PM/DM. We studied the relationship between endothelial damage and IP in PM/DM.
METHODS: Blood levels of sialylated carbohydrate antigen KL-6, TGF-beta, endothelin-1 (ET-1), thrombomodulin (TM), and plasminogen activator inhibitor-1 (PAI-1) were determined in 43 patients with PM or DM with or without IP, and the relationship between these measures was analyzed.
RESULTS: Blood levels of KL-6 and TGF-beta were higher in the patients with IP than those without, and these measures were well correlated with each other. Levels of ET-1, TM, and PAI-1, all known to reflect the extent of endothelial damage, were also increased in patients with IP, and these measures correlated well with TGF-beta.
CONCLUSION: Our data suggest that endothelial damage might play an important role through the production of fibrosis-enhancing factors such as TGF-beta or ET-1 in PM/DM.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16652421

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  13 in total

Review 1.  Dermatomyositis.

Authors:  M S Krathen; D Fiorentino; V P Werth
Journal:  Curr Dir Autoimmun       Date:  2008

2.  Cutaneous ulceration in dermatomyositis: association with anti-melanoma differentiation-associated gene 5 antibodies and interstitial lung disease.

Authors:  Neera S Narang; Livia Casciola-Rosen; Shufeng Li; Lorinda Chung; David F Fiorentino
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-05       Impact factor: 4.794

3.  The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study.

Authors:  David Fiorentino; Lorinda Chung; Jeff Zwerner; Antony Rosen; Livia Casciola-Rosen
Journal:  J Am Acad Dermatol       Date:  2011-04-29       Impact factor: 11.527

4.  Utility of Coagulation Markers for the Prediction of Rapidly Progressive Interstitial Lung Disease in Patients with Dermatomyositis.

Authors:  Tomoya Sagawa; Takashi Kida; Tohru Inaba; Isao Yokota; Risa Sagawa; Akiko Kasahara; Shunya Kaneshita; Takuya Inoue; Hidetake Nagahara; Kazuki Fujioka; Makoto Wada; Masataka Kohno; Yutaka Kawahito
Journal:  Lung       Date:  2019-06-25       Impact factor: 2.584

5.  Endothelial Activation Markers as Disease Activity and Damage Measures in Juvenile Dermatomyositis.

Authors:  Takayuki Kishi; Jonathan Chipman; Melvina Evereklian; Khanh Nghiem; Maryalice Stetler-Stevenson; Margaret E Rick; Michael Centola; Frederick W Miller; Lisa G Rider
Journal:  J Rheumatol       Date:  2019-08-01       Impact factor: 4.666

6.  High- density lipoprotein function is abnormal in idiopathic inflammatory myopathies.

Authors:  Sangmae Sharon Bae; Yuen Yin Lee; Ani Shahbazian; Jennifer Wang; David Meriwether; Ilana Golub; Buzand Oganesian; Tyler Dowd; Srinivasa T Reddy; Christina Charles-Schoeman
Journal:  Rheumatology (Oxford)       Date:  2020-11-01       Impact factor: 7.580

7.  Effects of bosentan on the skin lesions: an observational study from a single center in Japan.

Authors:  Masanori Funauchi; K Kishimoto; H Shimazu; Y Nagare; S Hino; T Yano; K Kinoshita
Journal:  Rheumatol Int       Date:  2008-11-27       Impact factor: 2.631

8.  Effect of different interferonα2 preparations on IP10 and ET-1 release from human lung cells.

Authors:  Rekha Badiger; Jane A Mitchell; Hime Gashaw; Neil A Galloway-Phillipps; Stefan Foser; Fernando Tatsch; Thomas Singer; Trevor T Hansel; Tobias Manigold
Journal:  PLoS One       Date:  2012-10-08       Impact factor: 3.240

9.  Phenotypes of Peripheral Blood Lymphocytes and Cytokine Expression in Polymyositis and Dermatomyositis before Treatment and after Clinical Remission.

Authors:  Yasuhiro Shimojima; Wataru Ishii; Masayuki Matsuda; Shu-Ichi Ikeda
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2012-10-18

10.  Endothelin-1 as a mediator and potential biomarker for interferon induced pulmonary toxicity.

Authors:  Peter M George; Morven E Cunningham; Neil Galloway-Phillipps; Rekha Badiger; William Alazawi; Graham R Foster; Jane A Mitchell
Journal:  Pulm Circ       Date:  2012-10       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.